13 Followers on Owler

Dyne Therapeutics

is a Massachusetts-based clinical-stage muscle disease company that researches and develops novel therapeutics for the treatment of genetic diseases... Read more
OverviewCompetitorsFundingNews & Insights

Dyne Therapeutics

is a Massachusetts-based clinical-stage muscle disease company that researches and develops novel therapeutics for the treatment of genetic diseases... Read more
Dyne Therapeutics President & CEO: John Cox

President & CEO

John Cox

CEO Approval Rating

88/100

2018

PublicNASDAQDYN

Pharmaceuticals & Biotechnology
Biotechnology
28362834 NAICS listing

Annual Revenue
<$1M
Employees
100
Funding
$2.8B

News

Funding
Jul 24, 2026
GlobeNewswire
Dyne Therapeutics received $431.4M in Post-IPO Equity Funding
Conference Presentation
May 13, 2026
GlobeNewswire
Dyne Therapeutics to Participate in Upcoming Investor Conferences

Dyne Therapeutics Competitors

1Avidity Biosciences
2Sarepta
3Aro Biotherapeutics
4Ionis Pharmaceuticals
5Gennao
6Keros
7Regulus
8Vertex Pharmaceuticals
9Neurana
Unlock 6 + competitors

Trending Companies